Multimodal Approach to the Intrathecal Catheter for Obstetric Accidental Dural Puncture

Sponsor
Centre Hospitalier Universitaire de Saint Etienne (Other)
Overall Status
Completed
CT.gov ID
NCT05910086
Collaborator
(none)
39
1
11.1
3.5

Study Details

Study Description

Brief Summary

Accidental dural puncture is an uncommon complication of epidural analgesia and can cause postdural puncture headache.

Condition or Disease Intervention/Treatment Phase
  • Other: collection of data from the medical record

Detailed Description

The aim of this study the effectiveness of a protocol implemented in our department, according to the recommendations of good practice, on the reduction of the use of blood patchs in patients who have had an accidental dural puncture during the implementation of their spinal anesthesia, in order to prevent the use of the blood patch. In addition, intensity of headaches is evaluated.

Study Design

Study Type:
Observational
Actual Enrollment :
39 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Multimodal Approach to the Intrathecal Catheter for Obstetric Accidental Dural Puncture
Actual Study Start Date :
Mar 1, 2022
Actual Primary Completion Date :
Feb 1, 2023
Actual Study Completion Date :
Feb 1, 2023

Arms and Interventions

Arm Intervention/Treatment
patients having an accidental dural puncture during the installation of an epidural anesthesia

patients having an accidental dural puncture during the installation of an epidural anesthesia will be included. Analysis datas of medical record.

Other: collection of data from the medical record
collection of data from the medical record: During epidural space puncture = cerebrospinal fluid (CSF) reflux, presence of glucose / strip, saline injection, intrathecal catheter insertion, intrathecal levobupivacaine and sufentanil injection, catheter insertion time, number of punctures, function of the person performing the procedure. Analgesia and hemodynamics during labor, blood pressure, pulse rate, amount of local anesthetic used, whether emergency cesarean section was performed Demographic data (age, weight, height, body mass index (BMI)) Post-partum monitoring of decubitus or orthostatic headaches, intensity, any other associated clinical signs Analgesics used and their efficacy The use of one or more blood patches, with the volume injected and their efficacy Identification of the breach during epidural analgesia or after delivery Call the patient at 1 week to reassess the episode and its consequences.

Outcome Measures

Primary Outcome Measures

  1. Number of epidural blood patch [Day: 7]

    Collect from medical records.

Secondary Outcome Measures

  1. headache intensity [Day: 7]

    Collect from medical records.

  2. Timeframe for blood patching [Day: 0]

    Collect from medical records the Timeframe for blood patching

  3. Number of blood patches required [Day: 7]

    Collect from medical records.

  4. Safety of the technique by number of adverse event [Day: 7]

    Collect from medical record the adverse event (complications).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients having an accidental dural puncture during the installation of an epidural anesthesia
Exclusion Criteria:
  • Patients without accidental dural puncture

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Saint-Etienne Saint-Étienne France

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

Investigators

  • Principal Investigator: Pascal MARTIN, MD, CHU Saint-Etienne

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier:
NCT05910086
Other Study ID Numbers:
  • IRBN632022/CHUSTE
First Posted:
Jun 18, 2023
Last Update Posted:
Jun 18, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire de Saint Etienne

Study Results

No Results Posted as of Jun 18, 2023